compounds(4) lead(4) cysteine protease(4) COVID-19(4) chymotrypsin(4) Drug development(4) reported(4) protease(4) severe adverse effect(4) adverse effects(4) inhibitor(4) Mutagenicity(4) Endpoint(4) approval(4) coronavirus(4) limitations(4) repurposing(4) assist(4) nucleocapsid protein(4) in silico toxicology(4) hepatotoxicity(4) cysteine(4) profiles(4) coronavirus disease(4) silico studies(4) prediction(4) exhibited(4) in silico(4) were assessed(4) Convalescent plasma therapy(4)